文献速递慢性静脉疾病

膝下大隐静脉反流治疗的系统综述

A systematic review of the treatment of residual below the knee venous reflux after endovenous thermal ablation of the great saphenous vein.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-08-21

该系统综述评估膝下大隐静脉(BK-GSV)干预对静脉疾病进展的影响,纳入15项研究。结果显示膝上+膝下腔内激光消融(AK+BK EVLA)较仅膝上EVLA显著降低BK-GSV反流复发(OR 0.1857,95%CI 0.076-0.4734,P<.0001)。对C4-C6疾病,若超声显示腹股沟至踝部反流,更积极治疗AK+BK-GSV是合理的。

要点

  • AK+BK EVLA较仅AK-EVLA显著降低BK-GSV反流复发(OR 0.1857,P<.0001)。
  • AK-EVLA与AK-HLS在BK-GSV反流复发上无显著差异(OR 0.85,P=.31)。
  • 对C4-C6疾病且超声示腹股沟至踝反流,可考虑更积极治疗AK+BK-GSV。

核心结论

  • 从腹股沟至踝部的轴向静水反流最好通过AK+BK-GSV消融控制。
  • 热消融BK-GSV的隐神经损伤发生率低于BK大隐静脉剥脱。

研究设计与样本

  • 遵循PRISMA指南的系统综述,检索PubMed和Embase数据库并交叉引用。
  • 纳入标准为BK-GSV疾病作为主要或次要结局的研究。
  • 共纳入15项研究,两名作者独立确定 eligibility 并提取数据。
  • 使用RevMan 5.3和SPSS进行统计计算。

主要发现

  • 15项研究中,6项评估AK高位结扎剥脱(HLS)后患者,7项评估AK-EVLA后,2项评估AK+BK EVLA后。
  • 共525条肢体接受HLS,696条接受AK-EVLA,147条接受AK+BK EVLA。
  • AK+BK EVLA较仅AK-EVLA显著降低BK-GSV反流复发(OR 0.1857,95%CI 0.076-0.4734,P<.0001)。
  • AK-HLS与AK+BK HLS的BK-GSV反流复发差异无统计学意义(OR 0.62,95%CI 0.27-1.43,P=.69)。
  • AK-EVLA与AK-HLS的BK-GSV反流复发差异无统计学意义(OR 0.85,95%CI 0.52-1.39,P=.31)。

关键数值与推荐

  • AK+BK EVLA与BK-GSV反流复发显著降低相关(OR 0.1857,95%CI 0.076-0.4734,P<.0001)。
  • AK-HLS与AK+BK HLS比较OR 0.62(95%CI 0.27-1.43,P=.69),差异不显著。
  • AK-EVLA与AK-HLS比较OR 0.85(95%CI 0.52-1.39,P=.31),差异不显著。
  • 对C4至C6疾病,若双功超声显示腹股沟至踝部反流,更积极治疗AK+BK-GSV是合理的。
  • BK-GSV热消融的隐神经损伤发生率低于BK大隐静脉剥脱。

临床怎么用

  • 对于C4-C6疾病且超声证实腹股沟至踝部反流的患者,可考虑AK+BK-GSV消融以更好控制反流。
  • 选择BK-GSV热消融而非剥脱可能降低隐神经损伤风险。
  • 需更多随机对照试验回答疾病复发和最佳技术问题。

局限性

  • 需要更多随机对照试验来回答涉及疾病复发和减轻复发的最佳技术问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Great saphenous vein (GSV) antireflux procedures have evolved during the past few decades to reduce elevated venous pressure. Untreated reflux in the below knee (BK) GSV (BK-GSV) can lead to persistent venous hypertension and deterioration of the venous circulation. The purpose of the present systematic review was to study the influence of BK-GSV intervention on venous disease progression. METHODS: A search was conducted, adhering to the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. The PubMed and Embase databases were searched and cross-referenced. Studies were included if they had met the inclusion criterion of BK-GSV disease as a primary or secondary outcome. Two of the authors independently determined the eligibility and extracted the relevant data. RevMan, version 5.3 (Cochrane Training, London, UK), and SPSS (IBM Corp, Armonk, NY) were used for statistical computation. RESULTS: Fifteen studies that had assessed BK-GSV reflux recurrence after ablative intervention were included in our analysis. Of the 15 studies, 6 had assessed patients after above knee (AK) high ligation and stripping (HLS), 7 after AK endovenous laser ablation (AK-EVLA), and 2 after AK- and BK-EVLA (AK+BK EVLA). In total, 525 limbs had undergone HLS, 696 AK-EVLA, and 147 AK+BK EVLA. AK+BK EVLA was associated with significantly lower odds of BK-GSV reflux recurrence compared with AK-EVLA only (odds ratio [OR], 0.1857; 95% confidence interval [CI], 0.076-0.4734; P < .0001). Although the odds of recurrent BK-GSV reflux appeared to be greater for patients who had undergone AK-HLS compared with AK+BK HLS, the difference was not statistically significant (OR, 0.62; CI, 0.27-1.43; P = .69). Finally, no statistically significant difference was observed in BK-GSV reflux recurrence between patients receiving AK-EVLA and those receiving AK-HLS (OR, 0.85; 95% CI, 0.52-1.39; P = .31). CONCLUSIONS: Axial hydrostatic reflux from the groin to ankle is best controlled with AK+BK-GSV ablation. However, GSV ablation can result in saphenous nerve injury. For C4 to C6 disease, more aggressive treatment of the AK+BK-GSV is justified if the duplex ultrasound findings demonstrate groin to ankle reflux. Thermal ablation of the BK-GSV has a lower incidence of saphenous nerve injury than does BK saphenous stripping. More randomized controlled trials are needed to answer questions involving disease recurrence and the best techniques to mitigate these recurrences.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Sussman MS, Ryon EL, Bahga A, et al. A systematic review of the treatment of residual below the knee venous reflux after endovenous thermal ablation of the great saphenous vein. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34425265. doi:10.1016/j.jvsv.2021.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。